Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
Nordisk Medicin|January 1, 1993
[Calcitonin as medication in pain?]O Spigset, T Mjörndal, E Vinge, et al.
Psychopharmacology|October 23, 1997
Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteersO Spigset, T Mjörndal
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 1, 1997
Serotonin 5-HT2A receptor binding in platelets from healthy subjects as studied by [3H]-lysergic acid diethylamide ([3H]-LSD): intra- and interindividual variabilityO Spigset, T Mjörndal
Scandinavian Journal of Clinical and Laboratory Investigation|March 18, 2004
Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumorO Spigset, A Kristoffersson, T Mjörndal
Biological Psychiatry|June 2, 1998
Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteersO Spigset, P Allard, T Mjörndal
International Psychogeriatrics|March 27, 2001
Serotonin 5-HT2A receptor binding in platelets from patients with Alzheimer's disease or vascular dementiaO Spigset, C Wilhelmsson, T Mjörndal, et al.
British Journal of Clinical Pharmacology|December 22, 1999
Effect of caffeine on clozapine pharmacokinetics in healthy volunteersS Hägg, O Spigset, T Mjörndal, et al.
Neuropsychobiology|November 24, 1999
Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adultsJ Sigurdh, O Spigset, P Allard, et al.
Biological Psychiatry|March 11, 1999
Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapyK Smedh, O Spigset, P Allard, et al.
The Journal of Clinical Psychiatry|July 22, 1998
Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medicationsS Hägg, L Joelsson, T Mjörndal, et al.
Pageof 28